| Document Date: 2014-10-14 07:41:11
Open Document File Size: 268,90 KBShare Result on Facebook
Company Novartis Pharmaceuticals UK Ltd / / / MedicalCondition congenital abnormality / cardiac arrest / atrial flutter / / MedicalTreatment renal transplantation / immunosuppression / heart transplant / / Organization European Medicines Agency / MHRA / Medicines and Healthcare products Regulatory Agency / Commission on Human Medicines / / Person Dimitrios Georgiopoulos / / / Position Chief Scientific Officer / Governor / / Product azathioprine / Simulect / / Technology transplantation / antibodies / / URL http /
SocialTag |
Simulect® (basiliximab): warning against off-label use in cardiac transplantation Dear Healthcare Professional, 8th September[removed]Novartis, in association with the European Medicines Agency and the Medicines and Healt